BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25660243)

  • 1. Postoperative follow-up of Cushing's disease using cortisol, desmopressin and coupled dexamethasone-desmopressin tests: a head-to-head comparison.
    Le Marc'hadour P; Muller M; Albarel F; Coulon AL; Morange I; Martinie M; Gay E; Graillon T; Dufour H; Conte-Devolx B; Chabre O; Brue T; Castinetti F
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):216-22. PubMed ID: 25660243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combined dexamethasone desmopressin test as an early marker of postsurgical recurrence in Cushing's disease.
    Castinetti F; Martinie M; Morange I; Dufour H; Sturm N; Passagia JG; Conte-Devolx B; Chabre O; Brue T
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1897-903. PubMed ID: 19276234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for postoperative cortisol response to desmopressin in predicting the risk for recurrent Cushing's disease.
    Romanholi DJ; Machado MC; Pereira CC; Danilovic DS; Pereira MA; Cescato VA; Cunha Neto MB; Musolino NR; de Mendonça BB; Salgado LR
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):117-22. PubMed ID: 18182093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrence of Cushing's disease preceded by the reappearance of ACTH and cortisol responses to desmopressin test.
    Dall'Asta C; Barbetta L; Bonavina L; Beck-Peccoz P; Ambrosi B
    Pituitary; 2004; 7(3):183-188. PubMed ID: 16328567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early post-operative ACTH and cortisol as predictors of remission in Cushing's disease.
    Acebes JJ; Martino J; Masuet C; Montanya E; Soler J
    Acta Neurochir (Wien); 2007; 149(5):471-7; discussion 477-9. PubMed ID: 17406780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The usefulness of combined biochemical tests in the diagnosis of Cushing's disease with negative pituitary magnetic resonance imaging.
    Testa RM; Albiger N; Occhi G; Sanguin F; Scanarini M; Berlucchi S; Gardiman MP; Carollo C; Mantero F; Scaroni C
    Eur J Endocrinol; 2007 Feb; 156(2):241-8. PubMed ID: 17287414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity.
    Tsagarakis S; Vasiliou V; Kokkoris P; Stavropoulos G; Thalassinos N
    Clin Endocrinol (Oxf); 1999 Oct; 51(4):473-7. PubMed ID: 10583315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Desmopressin Test Predicts Better Than Basal Cortisol the Long-Term Surgical Outcome of Cushing's Disease.
    Vassiliadi DA; Balomenaki M; Asimakopoulou A; Botoula E; Tzanela M; Tsagarakis S
    J Clin Endocrinol Metab; 2016 Dec; 101(12):4878-4885. PubMed ID: 27662440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing's disease.
    Colombo P; Dall'Asta C; Barbetta L; Re T; Passini E; Faglia G; Ambrosi B
    Eur J Endocrinol; 2000 Aug; 143(2):227-34. PubMed ID: 10913942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remission rate after transsphenoidal surgery in patients with pathologically confirmed Cushing's disease, the role of cortisol, ACTH assessment and immediate reoperation: a large single center experience.
    Hameed N; Yedinak CG; Brzana J; Gultekin SH; Coppa ND; Dogan A; Delashaw JB; Fleseriu M
    Pituitary; 2013 Dec; 16(4):452-8. PubMed ID: 23242860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
    Mayberg M; Reintjes S; Patel A; Moloney K; Mercado J; Carlson A; Scanlan J; Broyles F
    J Neurosurg; 2018 Nov; 129(5):1268-1277. PubMed ID: 29271716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The limited value of the desmopressin test in the diagnostic approach to Cushing's syndrome.
    Terzolo M; Reimondo G; Alì A; Borretta G; Cesario F; Pia A; Paccotti P; Angeli A
    Clin Endocrinol (Oxf); 2001 May; 54(5):609-16. PubMed ID: 11380491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low immediate postoperative serum-cortisol nadir predicts the short-term, but not long-term, remission after pituitary surgery for Cushing's disease.
    Ramm-Pettersen J; Halvorsen H; Evang JA; Rønning P; Hol PK; Bollerslev J; Berg-Johnsen J; Helseth E
    BMC Endocr Disord; 2015 Oct; 15():62. PubMed ID: 26499317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desmopressin stimulation test before and after pituitary surgery in patients with Cushing's disease.
    Losa M; Mortini P; Dylgjeri S; Barzaghi R; Franzin A; Mandelli C; Giovanelli M
    Clin Endocrinol (Oxf); 2001 Jul; 55(1):61-8. PubMed ID: 11453953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
    Yap LB; Turner HE; Adams CB; Wass JA
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The desmopressin test as a predictive factor of outcome after pituitary surgery for Cushing's disease.
    Valéro R; Vallette-Kasic S; Conte-Devolx B; Jaquet P; Brue T
    Eur J Endocrinol; 2004 Dec; 151(6):727-33. PubMed ID: 15588239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent adrenocorticotropin response to desmopressin in the early postoperative period predicts recurrence of Cushing's disease.
    Losa M; Bianchi R; Barzaghi R; Giovanelli M; Mortini P
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3322-8. PubMed ID: 19584185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An early post-operative ACTH suppression test can safely predict short- and long-term remission after surgery of Cushing's disease.
    Uvelius E; Höglund P; Valdemarsson S; Siesjö P
    Pituitary; 2018 Oct; 21(5):490-498. PubMed ID: 30039432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dexamethasone-suppressed corticotropin-releasing hormone stimulation test and the desmopressin test to distinguish Cushing's syndrome from pseudo-Cushing's states.
    Pecori Giraldi F; Pivonello R; Ambrogio AG; De Martino MC; De Martin M; Scacchi M; Colao A; Toja PM; Lombardi G; Cavagnini F
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):251-7. PubMed ID: 17223996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.